El linfoma de Burkitt es un linfoma de células B muy agresivo y el cáncer humano de proliferación más rápida.
Actualización clínica en niños y adolescentes | Linfoma de Burkitt Read More »
En todos los niveles de hernia de disco, la indicación quirúrgica absoluta incluye déficits neurológicos progresivos o síndrome de cauda equina. Sin embargo, existen indicaciones relativas a nivel cervical, torácico y lumbar.
¿Cuándo es necesaria la cirugía? | Hernias discales en diferentes localizaciones Read More »
The maker of subscription apps for insomnia and substance abuse began exploring strategic alternatives earlier this month, and is still seeking a sale.
Pear Therapeutics files for Chapter 11 bankruptcy Read More »
The investors accused Sernova’s board of “complacently” overseeing “a period of eroding shareholder value.”
Further EPA proposals involving medical device sterilization plants are expected to be forthcoming.
EPA proposes stricter ethylene oxide pollutant rules for chemical makers Read More »
The CEO of Fujifilm Healthcare Americas discusses integrating Hitachi’s diagnostic imaging business, new product launches and how hospital budgets are changing the market for imaging.
Friday Q&A: Fujifilm’s Henry Izawa on navigating a tough hospital equipment market Read More »
U.S. District Judge John Koeltl rejected UnitedHealth’s argument that New York’s surprise billing law prevents providers from taking legal action against payers for alleged underpayments.
New York judge denies UnitedHealth’s request for summary judgment in TeamHealth lawsuit Read More »
Results from two late-stage trials showed the Merck-Eisai combo treatment failed to boost survival in two difficult-to-treat advanced cancers.
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail Read More »
John Glaser, an executive in residence at Harvard Medical School, and Ranil Herath, president at Emeritus Healthcare, address healthcare’s digital transformation and how to successfully adapt to change.
Preparing for digital transformation in healthcare Read More »
Akebia Therapeutics, Inc. today announced that it will present posters at the National Kidney Foundation (NKF) Spring Clinical Meetings 2023 (SCM23), which will take place on demand and live in Austin, Texas.
